22-36937752-A-G

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000395.3(CSF2RB):ā€‹c.1944A>Gā€‹(p.Pro648Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.814 in 1,569,224 control chromosomes in the GnomAD database, including 522,375 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.77 ( 46289 hom., cov: 31)
Exomes š‘“: 0.82 ( 476086 hom. )

Consequence

CSF2RB
NM_000395.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.270
Variant links:
Genes affected
CSF2RB (HGNC:2436): (colony stimulating factor 2 receptor subunit beta) The protein encoded by this gene is the common beta chain of the high affinity receptor for IL-3, IL-5 and CSF. Defects in this gene have been reported to be associated with protein alveolar proteinosis (PAP). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 22-36937752-A-G is Benign according to our data. Variant chr22-36937752-A-G is described in ClinVar as [Benign]. Clinvar id is 226549.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-36937752-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.27 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.918 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CSF2RBNM_000395.3 linkuse as main transcriptc.1944A>G p.Pro648Pro synonymous_variant 14/14 ENST00000403662.8 NP_000386.1 P32927-1Q6NSJ8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CSF2RBENST00000403662.8 linkuse as main transcriptc.1944A>G p.Pro648Pro synonymous_variant 14/145 NM_000395.3 ENSP00000384053.3 P32927-1
CSF2RBENST00000406230.5 linkuse as main transcriptc.1962A>G p.Pro654Pro synonymous_variant 13/131 ENSP00000385271.1 P32927-2

Frequencies

GnomAD3 genomes
AF:
0.774
AC:
117655
AN:
151950
Hom.:
46252
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.637
Gnomad AMI
AF:
0.751
Gnomad AMR
AF:
0.821
Gnomad ASJ
AF:
0.785
Gnomad EAS
AF:
0.939
Gnomad SAS
AF:
0.876
Gnomad FIN
AF:
0.861
Gnomad MID
AF:
0.728
Gnomad NFE
AF:
0.814
Gnomad OTH
AF:
0.776
GnomAD3 exomes
AF:
0.833
AC:
149507
AN:
179536
Hom.:
62610
AF XY:
0.834
AC XY:
80324
AN XY:
96318
show subpopulations
Gnomad AFR exome
AF:
0.634
Gnomad AMR exome
AF:
0.886
Gnomad ASJ exome
AF:
0.784
Gnomad EAS exome
AF:
0.944
Gnomad SAS exome
AF:
0.866
Gnomad FIN exome
AF:
0.867
Gnomad NFE exome
AF:
0.809
Gnomad OTH exome
AF:
0.817
GnomAD4 exome
AF:
0.818
AC:
1159801
AN:
1417156
Hom.:
476086
Cov.:
87
AF XY:
0.819
AC XY:
574293
AN XY:
700912
show subpopulations
Gnomad4 AFR exome
AF:
0.625
Gnomad4 AMR exome
AF:
0.879
Gnomad4 ASJ exome
AF:
0.789
Gnomad4 EAS exome
AF:
0.945
Gnomad4 SAS exome
AF:
0.865
Gnomad4 FIN exome
AF:
0.866
Gnomad4 NFE exome
AF:
0.813
Gnomad4 OTH exome
AF:
0.815
GnomAD4 genome
AF:
0.774
AC:
117750
AN:
152068
Hom.:
46289
Cov.:
31
AF XY:
0.779
AC XY:
57930
AN XY:
74338
show subpopulations
Gnomad4 AFR
AF:
0.638
Gnomad4 AMR
AF:
0.822
Gnomad4 ASJ
AF:
0.785
Gnomad4 EAS
AF:
0.940
Gnomad4 SAS
AF:
0.876
Gnomad4 FIN
AF:
0.861
Gnomad4 NFE
AF:
0.814
Gnomad4 OTH
AF:
0.777
Alfa
AF:
0.803
Hom.:
55495
Bravo
AF:
0.767
Asia WGS
AF:
0.866
AC:
3013
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 28, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 24, 2014Pro648Pro in exon 14 of CSF2RB: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 34.1% (1489/4366) of African American chromosomes from a broad population by the NHLBI Exome Seque ncing Project (http://evs.gs.washington.edu/EVS; dbSNP rs131840). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.4
DANN
Benign
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs131840; hg19: chr22-37333794; COSMIC: COSV53256516; API